Symphony Medical Raises $10 Million
Symphony Medical, a privately-held company developing novel biocompatible polymer therapies to treat chronic heart failure and atrial fibrillation has raised $10 million in a Series […]
Blog
CryoLife: EPS Increases, Revenues Up 21%
Revenues at CryoLife rose 21% to $26.8 million in the third quarter of 2008. Net income was $3.6 million, or $0.13 per share, compared to […]
What’s Next for the Battered Laser Aesthetics Industry?
During times of economic malaise, discretionary income tends to decline. For many, it’s difficult to justify spending money on one’s appearance. Over the past several […]
NxStage: Medisystems Business Disappoints
NxStage Medical may be losing steam. The maker of dialysis products reported third quarter revenues of $30.5 million, a slight decrease from the $31.6 million […]
FDA Approves ATS Medical’s 3f Aortic Biprosthesis, 3f Enable Still in the Works
The FDA has approved ATS Medical’s 3f Aortic Bioprosthesis (3fAB), a poorly named, but potentially revolutionary pericardial aortic tissue valve. 3fAB’s blood flow dynamics and […]
Clarient: Q3 Revenues up 59%; Raises Guidance
Third quarter revenues at Clarient increased 59% to $19.0 million from the $11.9 million reported in Q3 2007. This marks the company’s 17th consecutive quarter […]
[Video Profile] Sherlock-NMD
When an athlete is injured, their career and value to the team are at risk. At all levels of athletics, including everyday fitness enthusiasts, the […]
Cynosure: Profitable, Growing and Flush with Cash, but Investors Don’t Care
Quarterly revenues at Cynosure, a developer of laser-based aesthetic systems, grew 21% year-over-year, from $31.5 million in Q3 2007 to $38.2 million in the most […]
Langer Sheds Orthotics Business to Cut the Fat
Only months after Langer sold its Bi-Op subsidiary for less than its purchase price, the company announced the sale of its custom orthotics business to […]
Nothing But Sunshine and Roses for Endologix, Save its Share Price
Endologix, developer of a treatment for abdominal aortic aneurysms (AAA), saw revenues increase 42% in its third quarter. The company reported $9.4 million in sales […]